English | Español
Patient Daily | Mar 4, 2026

CDC’s principal deputy director Ralph Abraham resigns amid leadership changes
Patient Daily | Mar 4, 2026

Merck restructures human health division ahead of Keytruda patent expiration
Patient Daily | Mar 4, 2026

Vanda receives FDA approval for new antipsychotic after previous setback
Patient Daily | Mar 4, 2026

FDA proposes regulatory path for individualized gene editing therapies targeting rare diseases
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts
Patient Daily | Mar 4, 2026

Appellate court rules for REGENXBIO over Sarepta in gene therapy patent case
Patient Daily | Mar 4, 2026

Novo Nordisk’s obesity drug fails key test against Eli Lilly rival
Patient Daily | Mar 4, 2026

Gilead announces plan to acquire Arcellx for $7.8 billion ahead of FDA decision

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy